Paper11272136
Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation.
Molano RD and 9 others. Diabetes, 2001. Cited by 87 papers, by iCite.
Cite this record
ConductScience Library. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation. Papers, record 11272136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11272136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| CD40 Antigens | Major topic |
| CD40 Ligand | Major topic |
| Islets of Langerhans Transplantation | Major topic |
| Mice, Inbred NOD | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| CD4-CD8 Ratio | |
| Diabetes Mellitus | |
| Diabetes Mellitus, Experimental | |
| Graft Survival | |
| Immunohistochemistry | |
| Islets of Langerhans | |
| Male | |
| Mice | |
| Mice, Inbred C57BL | |
| T-Lymphocyte Subsets | |
| Time Factors | |
| Transplantation, Homologous |
Source PubMed
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39606229 | Small-molecule inhibitors of the CD40-CD40L costimulatory interaction are effective in pancreatic islet transplantation and prevention of type 1 diabetes models. | Front Immunol | 2024 | https://conductscience.org/library/papers/39606229 | PubMed |
| 37543091 | Delayed graft rejection in autoimmune islet transplantation via biomaterial immunotherapy. | Am J Transplant | 2023 | https://conductscience.org/library/papers/37543091 | PubMed |
| 36506044 | Human stem cell derived beta-like cells engineered to present PD-L1 improve transplant survival in NOD mice carrying human HLA class I. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36506044 | PubMed |
| 32762460 | NOD Mice-Good Model for T1D but Not Without Limitations. | Cell Transplant | 2020 | https://conductscience.org/library/papers/32762460 | PubMed |
| 32216448 | Donor-Specific Regulatory T Cell-Mediated Immune Tolerance in an Intrahepatic Murine Allogeneic Islet Transplantation Model with Short-Term Anti-CD154 mAb Single Treatment. | Cell Transplant | 2020 | https://conductscience.org/library/papers/32216448 | PubMed |
| 31087105 | In vivo imaging of type 1 diabetes immunopathology using eye-transplanted islets in NOD mice. | Diabetologia | 2019 | https://conductscience.org/library/papers/31087105 | PubMed |
| 30191384 | Islet-Like Structures Generated In Vitro from Adult Human Liver Stem Cells Revert Hyperglycemia in Diabetic SCID Mice. | Stem Cell Rev Rep | 2019 | https://conductscience.org/library/papers/30191384 | PubMed |
| 29259578 | T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes. | Front Endocrinol (Lausanne) | 2017 | https://conductscience.org/library/papers/29259578 | PubMed |
| 26080071 | Combination of an Antigen-Specific Therapy and an Immunomodulatory Treatment to Simultaneous Block Recurrent Autoimmunity and Alloreactivity in Non-Obese Diabetic Mice. | PLoS One | 2015 | https://conductscience.org/library/papers/26080071 | PubMed |
| 24497465 | Long-term survival of allograft murine islets coated via covalently stabilized polymers. | Adv Healthc Mater | 2014 | https://conductscience.org/library/papers/24497465 | PubMed |
| 24354870 | Attenuation of donor-reactive T cells allows effective control of allograft rejection using regulatory T cell therapy. | Am J Transplant | 2014 | https://conductscience.org/library/papers/24354870 | PubMed |
| 24233663 | Transdisciplinary approach to restore pancreatic islet function. | Immunol Res | 2013 | https://conductscience.org/library/papers/24233663 | PubMed |
| 24203440 | Autoimmune effector memory T cells: the bad and the good. | Immunol Res | 2013 | https://conductscience.org/library/papers/24203440 | PubMed |
| 23031502 | Macroporous three-dimensional PDMS scaffolds for extrahepatic islet transplantation. | Cell Transplant | 2013 | https://conductscience.org/library/papers/23031502 | PubMed |
| 22566533 | Prevention of autoimmune diabetes and induction of β-cell proliferation in NOD mice by hyperbaric oxygen therapy. | Diabetes | 2012 | https://conductscience.org/library/papers/22566533 | PubMed |
| 21726515 | Differential outcomes in prediabetic vs. overtly diabetic NOD mice nonmyeloablatively conditioned with costimulatory blockade. | Exp Hematol | 2011 | https://conductscience.org/library/papers/21726515 | PubMed |
| 20491795 | The Type 1 Diabetes PhysioLab Platform: a validated physiologically based mathematical model of pathogenesis in the non-obese diabetic mouse. | Clin Exp Immunol | 2010 | https://conductscience.org/library/papers/20491795 | PubMed |
| 19453995 | Immunomodulation by blockade of the TRANCE co-stimulatory pathway in murine allogeneic islet transplantation. | Transpl Int | 2009 | https://conductscience.org/library/papers/19453995 | PubMed |
| 19401429 | Pig embryonic pancreatic tissue as a source for transplantation in diabetes: transient treatment with anti-LFA1, anti-CD48, and FTY720 enables long-term graft maintenance in mice with only mild ongoing immunosuppression. | Diabetes | 2009 | https://conductscience.org/library/papers/19401429 | PubMed |
| 18985310 | Inhibition of CD40-CD154 costimulatory pathway by a cyclic peptide targeting CD154. | J Mol Med (Berl) | 2009 | https://conductscience.org/library/papers/18985310 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11272136
GET https://conductscience.org/api/papers/v1/11272136/cited_by?page=2